Page last updated: 2024-10-28

hydroxyurea and Purpura, Thrombotic Thrombocytopenic

hydroxyurea has been researched along with Purpura, Thrombotic Thrombocytopenic in 2 studies

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Zahrani, H1
Gupta, V1
Minden, MD1
Messner, HA1
Lipton, JH1
Shammas, F1
Meyer, P1
Heikkila, R1
Apeland, T1
Gøransson, L1
Berland, J1
Kjellevold, K1

Reviews

1 review available for hydroxyurea and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Vascular events associated with alpha interferon therapy.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:3

    Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Foot Ulcer; Gangrene; Hemolytic-Uremic Syndrome

2003

Other Studies

1 other study available for hydroxyurea and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea.
    Acta haematologica, 1997, Volume: 97, Issue:3

    Topics: Antineoplastic Agents; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxyurea; Leukemia, Myelogenous

1997